Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials
Crossref DOI link: https://doi.org/10.1186/s13075-015-0880-2
Published Online: 2015-12-15
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Strand, Vibeke
Ahadieh, Sima
French, Jonathan
Geier, Jamie
Krishnaswami, Sriram
Menon, Sujatha
Checchio, Tina
Tensfeldt, Thomas G.
Hoffman, Elaine
Riese, Richard
Boy, Mary
Gómez-Reino, Juan J.
Funding for this research was provided by:
The article was funded by Pfizer Inc
